Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1538-7836.2007.02372.xPMID 17204132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.

  2005cited by this paper
• Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

  2005cited by this paper
• A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)

  2005cited by this paper
• Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

  2005cited by this paper
• Genetic Variations in the Tissue Factor Gene Are Associated With Clinical Outcome in Acute Coronary Syndrome and Expression Levels in Human Monocytes

  2005cited by this paper
• Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study

  2004cited by this paper
• Role of tissue factor in hemostasis, thrombosis, and vascular development.

  2004cited by this paper
• Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity

  2003cited by this paper
• Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects.

  2002cited by this paper
• Molecular Weight-Dependent Influence of Heparin on the Form of Tissue Factor Pathway Inhibitor Circulating in Plasma

  2001cited by this paper
• Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease

  2001cited by this paper
• Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences

  2001cited by this paper
• Structure and Biology of Tissue Factor Pathway Inhibitor

  2001cited by this paper
• Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II.

  2000cited by this paper
• Blood-borne tissue factor: another view of thrombosis.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina.

  1999cited by this paper
• Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

  1999cited by this paper
• Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.

  1998cited by this paper
• Comparison of plasma tissue factor levels in unstable and stable angina pectoris.

  1998cited by this paper
• Tissue factor expression on macrophages in coronary plaques in patients with unstable angina.

  1997cited by this paper
• Detection of Circulating Tissue Factor and Factor VII in a Normal Population

  1996cited by this paper
• Measurement of the free form of TFPI antigen in hyperlipidemia. Relationship between free and endothelial cell-associated forms of TFPI.

  1996cited by this paper
• Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction.

  1996cited by this paper
• Tissue factor pathway inhibitor (TFPI)--an update.

  1996cited by this paper
• Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens From Patients With Stable and Unstable Coronary Syndromes

  1995cited by this paper
• Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes.

  1995cited by this paper
• Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.

  1991cited by this paper
• Regulation of coagulation by a multivalent Kunitz-type inhibitor.

  1990cited by this paper
• Factor VII and extrinsic pathway inhibitor in acute coronary disease

  1989cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

  1988cited by this paper
• International Society on Thrombosis and Haemostasis

  1974cited by this paper

• Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies.

  2026cites this paper
• Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes

  2025cites this paper
• The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk.

  2025cites this paper
• Circadian misalignment disrupts biomarkers of cardiovascular disease risk and promotes a hypercoagulable state

  2024cites this paper
• Plasma tissue factor coagulation activity in post-acute myocardial infarction patients

  2022cites this paper
• Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.

  2022cites this paper
• Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway

  2022cites this paper
• NLRP3 Inflammasome Overactivation in Patients with Aneurysmal Subarachnoid Hemorrhage

  2022cites this paper
• Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis

  2022cites this paper
• Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway

  2022cites this paper
• Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study

  2021cites this paper
• Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis.

  2020cites this paper
• The impact of TFPI on coronary atherosclerotic burden.

  2018cites this paper
• Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses.

  2018cites this paper
• Detection of biomarkers using a novel proximity extension assay in patients with ST-elevation myocardial infarction.

  2018cites this paper
• Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population

  2018cites this paper
• Genome-Wide Linkage Analysis of Large Multiple Multigenerational Families Identifies Novel Genetic Loci for Coronary Artery Disease

  2017cites this paper
• Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels

  2017cites this paper
• Pro-coagulant activity during exercise testing in patients with coronary artery disease

  2017cites this paper
• Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism

  2016cites this paper
• Circulating Tissue Factor Levels and Risk of Stroke: Findings From the EPICOR Study

  2015cites this paper
• Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor

  2015cites this paper
• The Levels of PAI-1, Urokinase uPA, Thrombomodulin and TFPI in Essential Thrombocythemia

  2015cites this paper
• Lack of association between potential prothrombotic genetic risk factors and arterial and venous thrombosis.

  2015cites this paper
• Genetic determinants of tissue factor pathway inhibitor plasma levels

  2015cites this paper
• Tissue factor and atherothrombosis.

  2015cites this paper
• Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice.

  2015cites this paper
• 1502 Stroke June 2015 contribute to a procoagulant state in patients with acute cardiac and brain

  2015cites this paper
• The Correlation Between Plasma Tissue Factor and Interleukin 18 and Their Significance in Patients with Acute Coronary Syndrome

  2015cites this paper
• Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease

  2014cites this paper
• Ocena zmian okołooperacyjnych poziomu czynnika tkankowego (TF) i jego inhibitora (TFPI) u chorych z tętniakiem aorty brzusznej leczonych metodą klasyczną i wewnątrznaczyniową

  2014cites this paper
• Les toxines urémiques provoquent un phénotype procoagulant de l'endothelium par la voie du facteur de transcription AHR

  2013cites this paper
• Anticoagulation during and after acute coronary syndrome

  2013cites this paper
• The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.

  2013cites this paper
• Plasma tissue factor pathway inhibitor levels in angiographically defined coronary artery disease among saudis.

  2013cites this paper
• Prognostic impact of tissue factor pathway on long-term ischemic events of ST-elevated myocardial infarction treated with a primary percutaneous coronary intervention.

  2013cites this paper
• The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.

  2012cites this paper
• Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: The Athero Gene Study

  2012cites this paper
• Tissue factor in health and disease.

  2012cites this paper
• In search for novel biomarkers of acute coronary syndrome.

  2012cites this paper
• A603G tissue factor gene polymorphism and mediators of immune inflammation in patients with arterial hypertension and coronary heart disease

  2012cites this paper
• Traditional and Novel Risk Factors in Atherothrombosis

  2012cites this paper
• Патогенетическая роль тканевого фактора в атеротромбозе и дисфункции эндотелия Е.И. Красильникова¹ , ², Е.Г. Сергеева¹, Д. Саха¹, С. Саха¹, А.В. Горбач¹,

  2012cites this paper
• Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease.

  2012cites this paper
• Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?

  2011cites this paper
• Evaluation of endothelial function and thrombotic system in children whose parents had early onset coronary heart disease

  2011cites this paper
• Plasma tissue factor, tissue factor pathway inhibitor and restenosis following femoropopliteal percutaneous transluminal angioplasty in claudicants

  2011cites this paper
• Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study

  2011cites this paper
• The Influence of Tissue Factor and Tissue Factor Pathway Inhibitor Polymorphisms on Thrombin Generation in Stable Coronary Artery Disease

  2011cites this paper
• Tissue Factor Pathway Inhibitor: A New Link Among Arterial Stiffness, Pulse Pressure, and Coagulation in Postmenopausal Women

  2011cites this paper
• Simulated surface-induced thrombin generation in a flow field.

  2011cites this paper
• Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis

  2011cites this paper
• Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina.

  2011cites this paper
• Circulating thrombotic and haemostatic components in patients with coronary artery disease

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Original clinical investigation Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes

  2010cites this paper
• Biomarkers in ischemic cardiac syndromes

  2010cites this paper
• Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma – a pilot study

  2009cites this paper
• Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

  2009cites this paper
• Systemic blood coagulation activation in acute coronary syndromes.

  2009cites this paper
• The role of tissue factor and tissue factor pathway inhibitor in health and disease states.

  2009cites this paper
• Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction

  2009influential citation
• Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

  2009cites this paper
• Tissue factor gene polymorphisms and haplotypes and the risk of ischemic vascular events: four studies and a meta‐analysis

  2009cites this paper
• Tissue factor activity of blood mononuclear cells is increased after total knee arthroplasty

  2009cites this paper
• Frontiers in Research Review: Better Understanding of Disease Mechanism: From Phenotype to Genotype CARDIAC TISSUE FACTOR: ROLES IN PHYSIOLOGY AND FIBROSIS

  2008cites this paper
• A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor

  2008cites this paper
• Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test

  2008cites this paper
• Combined Effect of Hemostatic Gene Polymorphisms and the Risk of Myocardial Infarction in Patients with Advanced Coronary Atherosclerosis

  2008cites this paper
• Tissue Factor Pathway Inhibitor: Structure and Function

  2008cites this paper
• Hypercoagulable States in Cardiovascular Disease

  2008cites this paper
• Circulating tissue factor-exposing microparticles.

  2008cites this paper
• Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells

  2008cites this paper
• Reduced factor VII and factor VIII levels and prolonged thrombin‐generation times during a healthy diet in middle‐aged women with mild to moderate cardiovascular disease risk

  2008cites this paper
• CARDIAC TISSUE FACTOR: ROLES IN PHYSIOLOGY AND FIBROSIS

  2008cites this paper
• Regulation of Tissue Factor and Coagulation Activity : Translation Studies with Focus on Platelet-Monocyte Aggregates and Patients with Acute Coronary Syndrome

  2008cites this paper
• Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease

  2007cites this paper
• Factor XIa and tissue factor activity in patients with coronary artery disease

  2007cites this paper
• Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass

  2007cites this paper
• Is tissue factor the ‘original sin’ of clotting, or is it factor VII?

  2007cites this paper
• Open Access Original Clinical Investigation Original Clinical Investigation

  year unknowncites this paper